Penile cavernous vasoactive substance injection

Penile cavernous vasoactive substance injection test as a means of diagnosing erectile dysfunction, can identify mental impotence and vascular impotence, can also be used to treat mental impotence, endocrine impotence, neurological impotence, and other methods Treatment of vascular impotence and mixed erectile dysfunction. Inject vasoactive drugs into the penis. Basic Information Specialist classification: male examination inspection classification: biochemical examination Applicable gender: whether the male is fasting: not fasting Tips: Actively cooperate with the doctor's normal work value Normal people do not need to inject the corpus cavernosum vasoactive penis to normal erection. Clinical significance Abnormal results Injecting vasoactive drugs into the corpus cavernosum can induce penile erection in patients with psychotic, neurological, hormonal, and mild vascular ED, especially in patients with neurological ED. Patients who need to be examined for mental impotence, endocrine impotence, and vascular impotence. Precautions Contraindications before examination: The intracavernosal injection method of the penis is simple and practical, with rapid onset and effective effect, but there are certain side effects and complications, which should be prevented, and attention should be paid to treatment. (1) continuous erection of the penis: the most serious complication of intracavernous injection, it is generally believed that the erection of the penis for 6 hours or more after the injection is the continuous erection of the penis. See the treatment of abnormal penile erection. (2) Penile pain: Most of the penile pain is mild to moderate, and it is rarely stopped due to pain. (3) Local adverse reactions of the penis: injection site blood stasis, penile rash, penile edema, penile fibrosis, balanitis, bleeding at the injection site, injection site infection, itching at the injection site, swelling at the injection site, urethral bleeding and penile fever, numbness , irritation, phimosis, itching, erythema, venous leakage, erectile pain and ejaculation abnormalities. (4) systemic adverse reactions: testicular pain, testicular swelling, scrotal erythema, scrotal pain, frequent urination, urgency, dysuria, hypotension, hypertension, supraventricular premature beats, peripheral vascular disease, dizziness, sensation of dullness, weakness of the arms Local pain (hip, thigh, genital, abdominal pain), headache, pelvic pain, back pain. (5) Changes in hemodynamics: lower blood pressure and increased pulse. Requirements for inspection: Actively cooperate with the doctor's work. Inspection process Inject vasoactive drugs into the penis. Currently commonly used drugs are: a single dose of papaverine in 10 ~ 30mg, prostaglandin E1 is 5 ~ 40μg. The triple mixed preparation was papaverine 30 mg/ml, phentolamine 0.5 mg/ml and prostaglandin E 110 μg/ml. The two mixed preparations were papaverine 30 mg/ml and phentolamine 0.5 mg/ml, or phentolamine 0.5 mg/ml and prostaglandin E 110 μg/ml. The dosage of the mixed preparation is 0.1~2ml, and gradually increases from the small dose to the optimal dose, and the usual dose is 0.25~1ml. Not suitable for the crowd Inappropriate population: patients who are allergic to vasoactive substances (prostaglandin E1), patients with sickle cell anemia, multiple myeloma, leukemia and easy to induce abnormal erection, patients with penile cavernous fibrosis, penile prosthesis, severe People with cardiovascular disease, severe heart rhythm disorder, low blood pressure, and old age should be banned or used with caution.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.